Evaluation of the Effect of Long-term Lipid-lowering Therapy in STEMI Patients With Coronavirus Infection COVID-19
NCT04900155
·
clinicaltrials.gov ↗
NA
Phase
UNKNOWN
Status
45
Enrollment
OTHER
Sponsor class
Conditions
STEMI
Covid19
NSTEMI
Interventions
DRUG:
Atorvastatin 80mg
DRUG:
Atorvastatin-Ezetimibe
Sponsor
Penza State University